Page last updated: 2024-10-24

cefuroxime and Prostatic Hyperplasia

cefuroxime has been researched along with Prostatic Hyperplasia in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.

Research Excerpts

ExcerptRelevanceReference
"From 33 patients with prostatic adenoma with an average age of 68."1.26[Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)]. ( Adam, D; Boettger, F; Schalkhäuser, K, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, D1
Schalkhäuser, K1
Boettger, F1

Other Studies

1 other study available for cefuroxime and Prostatic Hyperplasia

ArticleYear
[Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)].
    Medizinische Klinik, 1979, Dec-07, Volume: 74, Issue:49

    Topics: Adult; Aged; Cefuroxime; Cephalosporins; Electrosurgery; Humans; Male; Middle Aged; Prostate; Prosta

1979